跳至主要内容
临床试验/ACTRN12605000401651
ACTRN12605000401651招募中不适用

Assessment of the safety and efficacy of fondaparinux as an anticoagulant in haemofiltraion in patients with acute renal failure

Intensive Care Unit, RMH0 个研究点目标入组 20 人开始时间: 2005年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • The study will be conducted in the Intensive Care Unit at The Royal Melbourne Hospital and will aim to include patients who fulfill the following criteria: 1.Adult patients admitted to the ICU with an expected stay of more than 48h. 2.Patients who require continuous renal replacement therapy. 3.Patients who consent or if the patient is incompetent, the next-of-kin who consent, to inclusion in the study.

排除标准

  • 1.Patients who are pregnant. 2.Patients with a contra-indication to anticoagulation for pre-existing bleeding diathesis. 3.Patients or next-to-kin who do not consent to study inclusion.

研究者

发起方
Intensive Care Unit, RMH

相似试验

已完成
不适用
Evaluation of the efficacy and the safety of processed onion product on human muscle metabolism for the inpatient.Inpatient
JPRN-UMIN000006087The University of Tokushima20
招募中
2 期
Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19COVID-19.COVID-19U07.1
IRCT20150808023559N23Ardabil University of Medical Sciences100
进行中(未招募)
不适用
A study of DoTiNurad aiming to treat hyperuricemia with CKDPatients with hyperuricemia whose renal function is in the GFR range of G1 to G4
JPRN-jRCTs061210079Wada Jun100
已完成
不适用
Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virusEbola virus disease
JPRN-UMIN000016101ational Center for Global Health and Medicine5
进行中(未招募)
1 期
se of an antidiabetic drug (Empagliflozin) to lower the blood level of 1,5-anhydroglucitol in patients deficient in the glucose-6-phosphate transporter (GSD1b) and the phosphatase G6PC3, both of the endoplasmic reticulum, to treat their recurrent infections by normalizing their blood neutrophil counts. Neutrophils are the most abundant white blood cells in our blood that are essential to help fighting infections. 1,5-anhydroglucitol is a sugar derivative with no known function.(1) Severe Congenital Neutropenia type 4 (SNC4) due to a deficiency in G6PC3, a phosphatase of the endoplasmic also known a Ubiquitous glucose-6-phosphatase and (2) the neutropenia in Glycogen Storage Disease type 1b due to a deficiency in the glucose-6-phosphate transporter (G6PT / SLC37A4) of the endoplasmic reticulum.
EUCTR2018-004191-35-BECliniques universitaires Saint-Luc5